Caveolin-1 inhibitors belong to a significant class of chemical compounds that have garnered attention due to their impact on cellular processes. These inhibitors specifically target caveolin-1, a crucial protein involved in the formation of caveolae, which are small invaginations or cave-like structures present on the cell membrane. Caveolin-1 itself plays a pivotal role in various cellular functions, including endocytosis, lipid trafficking, and signal transduction. Inhibitors of caveolin-1 are designed to modulate these processes by disrupting the interaction between caveolin-1 and other proteins or lipids, which can ultimately lead to alterations in cellular signaling and membrane dynamics.
Structurally, caveolin-1 inhibitors are often developed based on a deep understanding of the three-dimensional conformation of caveolin-1 and its interactions with other molecules. These inhibitors can function by binding to specific domains of caveolin-1 or by interfering with its association with lipid rafts, which are specialized microdomains in the cell membrane. By targeting these interactions, caveolin-1 inhibitors may have the ability to influence cellular trafficking, membrane organization, and the compartmentalization of signaling molecules. The mechanistic intricacies of how these inhibitors perturb caveolin-1 functions are an area of active research. Researchers are continually investigating the diverse implications of caveolin-1 inhibitors in cellular systems. Understanding the ways in which these inhibitors affect caveolin-1 interactions could shed light on fundamental cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits caveolin-1 by disrupting its interaction with tyrosine kinases, leading to reduced signaling. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin sequesters cholesterol, disrupting caveolin-1's association with lipid rafts and signaling. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin reduces caveolin-1 expression by inhibiting the mevalonate pathway, impacting caveolin-1 localization. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin disrupts lipid rafts by binding to ergosterol, affecting caveolin-1 localization and cellular processes. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin III binds to cholesterol, leading to caveolin-1 dissociation from lipid rafts and altered cellular functions. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits caveolin-1 via mevalonate pathway blockade, influencing its involvement in cellular signaling. | ||||||
Ro 48-8071 fumarate | 189197-69-1 | sc-215817 sc-215817A | 10 mg 50 mg | $94.00 $411.00 | ||
Ro 48-8071 Fumarate inhibits caveolin-1 phosphorylation, affecting its interaction with signaling molecules and downstream events. | ||||||